BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10999465)

  • 1. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer.
    Pellegrini P; Contasta I; Berghella AM; Gargano E; Mammarella C; Adorno D
    Cancer Immunol Immunother; 2000 Sep; 49(7):388-94. PubMed ID: 10999465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.
    Waas ET; Hendriks T; Lomme RM; Wobbes T
    Dis Colon Rectum; 2005 Apr; 48(4):700-10. PubMed ID: 15906450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.
    Contasta I; Berghella AM; Pellegrini P; Del Beato T; Casciani CA; Adorno D
    Cancer Biother Radiopharm; 1999 Dec; 14(6):465-75. PubMed ID: 10850333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.
    Liang Y; Tang W; Huang T; Gao Y; Tan A; Yang X; Zhang H; Hu Y; Qin X; Li S; Zhang S; Mo L; Liang Z; Shi D; Huang Z; Guan Y; Zhou J; Winkler C; O'Brien SJ; Xu J; Mo Z; Peng T
    PLoS One; 2014; 9(6):e97923. PubMed ID: 24941225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
    Yin SS; Li XM; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
    Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
    Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients.
    Ochiai H; Ohishi T; Osumi K; Tokuyama J; Urakami H; Seki S; Shimada A; Matsui A; Isobe Y; Murata Y; Endo T; Ishii Y; Hasegawa H; Matsumoto S; Kitagawa Y
    Surg Today; 2012 Jan; 42(2):164-8. PubMed ID: 22075664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
    An HJ; Lee YJ; Hong SA; Kim JO; Lee KY; Kim YK; Park JK; Kang JH
    Pathol Res Pract; 2016 May; 212(5):357-64. PubMed ID: 26995105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
    Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
    Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
    Nielsen HJ; Christensen IJ; Brünner N
    Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
    Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
    Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
    Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
    Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictive markers for patients with advanced colorectal cancer.
    Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
    Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
    Vočka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
    Int J Biol Markers; 2019 Sep; 34(3):292-301. PubMed ID: 31578137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.